Immune Response BioPharma, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Immune Response BioPharma, Inc.
Johnson & Johnson's quadruple HIV combination is likely to win a positive recommendation for approval in Europe this week – but clever positioning will be required to secure strong uptake for the combination considering its late entry onto a competitive market place.
- Other Names / Subsidiaries
- The Immune Response Corporation
- Orchestra Therapeutics, Inc.
- Orchestra Therapeutics New